🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
36 results for “Astellas”
MedicineActive substanceLicence holderStatus
Advagraf 0.5 mg prolonged-release hard capsules
EU/1/07/387/001-002
Tacrolimus Astellas Pharma Europe BV
Advagraf 0.5 mg prolonged-release hard capsules
EU/1/07/387/1-2
Tacrolimus Astellas Pharma Europe BV
Advagraf 1 mg prolonged-release hard capsules
EU/1/07/387/003-006
Tacrolimus Astellas Pharma Europe BV
Advagraf 1 mg prolonged-release hard capsules
EU/1/07/387/3-6
Tacrolimus Astellas Pharma Europe BV
Advagraf 3 mg prolonged-release hard capsules
EU/1/07/387/011-013
Tacrolimus Astellas Pharma Europe BV
Advagraf 3 mg prolonged-release hard capsules
EU/1/07/387/11-13
Tacrolimus Astellas Pharma Europe BV
Advagraf 5 mg prolonged-release hard capsules
EU/1/07/387/007-008
Tacrolimus Astellas Pharma Europe BV
Advagraf 5 mg prolonged-release hard capsules
EU/1/07/387/7-8
Tacrolimus Astellas Pharma Europe BV
Betmiga 25 mg prolonged-release tablets
EU/1/12/809/001-007
Mirabegron (ym178) Astellas Pharma Europe BV
Betmiga 50 mg prolonged-release tablets
EU/1/12/809/008-014
Mirabegron (ym178) Astellas Pharma Europe BV
Betmiga 8 mg/ml Granules for prolonged-release oral suspension
EU/1/12/809/019-020
Mirabegron Astellas Pharma Europe B.V.
Evrenzo 100 mg Film-coated tablet
EU/1/21/1574/004
Roxadustat Astellas Pharma Europe B.V.
Evrenzo 150 mg Film-coated tablet
EU/1/21/1574/005
Roxadustat Astellas Pharma Europe B.V.
Evrenzo 20 mg Film-coated tablet
EU/1/21/1574/001
Roxadustat Astellas Pharma Europe B.V.
Evrenzo 50 mg Film-coated tablet
EU/1/21/1574/002
Roxadustat Astellas Pharma Europe B.V.
Evrenzo 70 mg Film-coated tablet
EU/1/21/1574/003
Roxadustat Astellas Pharma Europe B.V.
Modigraf 0.2 mg granules for oral suspension
EU/1/09/523/001
Tacrolimus Astellas Pharma Europe BV
Modigraf 1 mg granules for oral suspension
EU/1/09/523/002
Tacrolimus Astellas Pharma Europe BV
Omnexel®, 400 micrograms prolonged release tablets, film-coated
PA1241/006/001
Tamsulosin hydrochloride Astellas Pharma Co. Limited Marketed
Padcev 20 mg Powder for concentrate for solution for infusion
EU/1/21/1615/001
Enfortumab Vedotin Astellas Pharma Europe B.V.
Padcev 30 mg Powder for concentrate for solution for infusion
EU/1/21/1615/002
Enfortumab Vedotin Astellas Pharma Europe B.V.
Prograf 0.5 mg hard capsules
PA1241/014/001
Tacrolimus Astellas Pharma Co. Limited Marketed
Prograf 1 mg hard capsules
PA1241/014/002
Tacrolimus Astellas Pharma Co. Limited Marketed
Prograf 5 mg hard capsules
PA1241/014/003
Tacrolimus Astellas Pharma Co. Limited Marketed
Prograf 5 mg/ml concentrate for solution for infusion
PA1241/014/004
Tacrolimus Astellas Pharma Co. Limited Marketed
Protopic 0.1% Ointment
EU/1/02/202/003
Tacrolimus Astellas Pharma GmbH
Veoza 45 mg film-coated tablets
EU/1/23/1771/001-003
Fezolinetant Astellas Pharma Europe B.V.
Vesitirim 1 mg/ml oral suspension
PA1241/009/003
Solifenacin succinate Astellas Pharma Co. Limited Marketed
Vesitirim 10 mg film-coated tablets
PA1241/009/002
Solifenacin succinate Astellas Pharma Co. Limited Marketed
Vesitirim 5 mg film-coated tablets
PA1241/009/001
Solifenacin succinate Astellas Pharma Co. Limited Marketed
Vesomni 6 mg/0.4 mg modified-release tablets
PA1241/016/001
Solifenacin succinate, Tamsulosin hydrochloride Astellas Pharma Co. Limited Marketed
Vyloy 100 mg powder for concentrate for solution for infusion.
EU/1/24/1856/001-002
Zolbetuximab Astellas Pharma Europe B.V.
Xospata 40 mg film-coated tablets
EU/1/19/1399/001
Gilteritinib fumarate Astellas Pharma Europe B.V.
Xtandi 40 mg film-coated tablets
EU/1/13/846/002
Enzalutamide Astellas Pharma Europe B.V.
Xtandi 40 mg soft capsules
EU/1/13/846/001
Enzalutamide Astellas Pharma Europe BV
Xtandi 80 mg film-coated tablets
EU/1/13/846/003
Enzalutamide Astellas Pharma Europe B.V.
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.